Immunic, Inc. (IMUX) stock forecast and price target
Price $7.52 · data as of November 13, 2026
12-month price target
Average target$42.64
Upside / downside+467.0%
Analysts11
ConsensusStrong buy
Low $20.00Average $42.64High $85.00
Gold marker: average target · white marker: today’s price ($7.52)
Analyst ratings
Strong buy 0Buy 13Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-3.60 | +42.0% | $0 |
| Next fiscal year ends December 31, 2027 | $-2.39 | +33.5% | $0 |
| Next quarter ends December 31, 2026 | $-0.76 | −8.4% | $0 |
| Quarter after ends March 31, 2027 | $-0.72 | +33.3% | $0 |
Consensus of the analysts covering Immunic, updated daily. In the last 30 days 6 estimates were raised and 3 lowered.
Frequently asked questions
What is the Immunic stock price target?
The average 12-month target from 11 analysts is $42.64, 467.0% above the current price of $7.52 Targets range from $20.00 to $85.00.
Is Immunic a buy according to analysts?
The consensus rating is “Strong buy” (13 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Immunic expected to earn?
Analysts expect EPS of $-3.60 for the fiscal year ending December 31, 2026 and $-2.39 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.